Healthcare provider profile · identity verified

Peter Kuta

Nurse Practitioner · ELMHURST, IL · NPI 1508382375

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	999	55
Atorvastatin Calcium	Atorvastatin Calcium	892	62
Amlodipine Besylate	Amlodipine Besylate	798	52
Potassium Chloride	Potassium Chloride	694	59
Memantine Hcl	Memantine Hcl	686	42
Furosemide	Furosemide	665	59
Donepezil Hcl	Donepezil Hcl	583	34
Pantoprazole Sodium	Pantoprazole Sodium	504	37
Sertraline Hcl	Sertraline Hcl	465	27
Metoprolol Succinate	Metoprolol Succinate	447	36
Metoprolol Tartrate	Metoprolol Tartrate	436	31
Escitalopram Oxalate	Escitalopram Oxalate	431	31
Lisinopril	Lisinopril	365	30
Eliquis	Apixaban	357	26
Mirtazapine	Mirtazapine	303	21
Losartan Potassium	Losartan Potassium	282	27
Gabapentin	Gabapentin	257	18
Clopidogrel	Clopidogrel Bisulfate	230	14
Tamsulosin Hcl	Tamsulosin Hcl	216	18
Quetiapine Fumarate	Quetiapine Fumarate	214	15
Trazodone Hcl	Trazodone Hcl	212	16
Metformin Hcl	Metformin Hcl	209	14
Simvastatin	Simvastatin	198	12
Torsemide	Torsemide	191	14
Carvedilol	Carvedilol	169	suppressed
Citalopram Hbr	Citalopram Hydrobromide	169	14
Xarelto	Rivaroxaban	165	11
Atenolol	Atenolol	158	suppressed
Famotidine	Famotidine	141	12
Omeprazole	Omeprazole	139	12
Buspirone Hcl	Buspirone Hcl	135	suppressed
Prednisone	Prednisone	130	15
Hydralazine Hcl	Hydralazine Hcl	124	suppressed
Warfarin Sodium	Warfarin Sodium	114	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	98	suppressed
Glimepiride	Glimepiride	97	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	97	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	96	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	96	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	96	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	94	suppressed
Latanoprost	Latanoprost	88	11
Carbidopa-Levodopa	Carbidopa/Levodopa	87	suppressed
Spironolactone	Spironolactone	83	suppressed
Ezetimibe	Ezetimibe	82	suppressed
Allopurinol	Allopurinol	80	suppressed
Diclofenac Sodium	Diclofenac Sodium	77	suppressed
Alendronate Sodium	Alendronate Sodium	76	suppressed
Amiodarone Hcl	Amiodarone Hcl	75	suppressed
Risperidone	Risperidone	75	suppressed
Alprazolam	Alprazolam	74	17
Pravastatin Sodium	Pravastatin Sodium	69	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	16
Levetiracetam	Levetiracetam	67	suppressed
Nystatin	Nystatin	66	25
Finasteride	Finasteride	65	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	64	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	64	suppressed
Methenamine Hippurate	Methenamine Hippurate	64	suppressed
Olanzapine	Olanzapine	62	suppressed
Sucralfate	Sucralfate	60	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	59	45
Montelukast Sodium	Montelukast Sodium	59	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	55	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	52	suppressed
Loperamide	Loperamide Hcl	50	18
Tramadol Hcl	Tramadol Hcl	50	21
Diltiazem 24hr Er (La)	Diltiazem Hcl	49	suppressed
Myrbetriq	Mirabegron	49	suppressed
Desipramine Hcl	Desipramine Hcl	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	45	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	43	suppressed
Bumetanide	Bumetanide	42	suppressed
Bupropion Hcl	Bupropion Hcl	41	suppressed
Entresto	Sacubitril/Valsartan	40	suppressed
Cephalexin	Cephalexin	39	12
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Valsartan	Valsartan	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Midodrine Hcl	Midodrine Hcl	37	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	36	suppressed
Divalproex Sodium	Divalproex Sodium	32	suppressed
Folic Acid	Folic Acid	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	25
Baclofen	Baclofen	29	suppressed
Nystop	Nystatin	29	16
Jardiance	Empagliflozin	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	suppressed
Anastrozole	Anastrozole	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Diltiazem Hcl	Diltiazem Hcl	26	suppressed
Fentanyl	Fentanyl	26	suppressed
Glipizide	Glipizide	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Timolol Maleate	Timolol Maleate	26	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	26	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	25	suppressed
Galantamine Er	Galantamine Hbr	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	16
Probenecid	Probenecid	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Lovastatin	Lovastatin	24	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Ibandronate Sodium	Ibandronate Sodium	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Digoxin	Digoxin	22	suppressed
Levofloxacin	Levofloxacin	20	18
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Memantine Hcl Er	Memantine Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Imipramine Hcl	Imipramine Hcl	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Naproxen	Naproxen	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	15	suppressed
Trimethoprim	Trimethoprim	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	14	suppressed
Haloperidol	Haloperidol	13	suppressed
Leflunomide	Leflunomide	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error